Corlopam

Active Ingredient(s): Fenoldopam
FDA Approved: * September 23, 1997
Pharm Company: * HOSPIRA
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Corlopam Overview

Fenoldopam mesylate (Corlopam) is a drug and synthetic benzazepine derivative which acts as a selective D1 receptor partial agonist.[1] Fenoldopam is used as an antihypertensive agent.[2] It was approved by the Food and Drug Administration (FDA) in September 1997.[3] Contents 1 Indications 2 Pharmacology 3 Side effects 4 Contraindications, warnings and precautions 5 References Indications Fenoldopam is used as an antihypertensive agent ...

Read more Corlopam Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fenoldopam

Recent Corlopam Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fenoldopam
  • Injection: 10mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Corlopam: (2 results)

Sorted by National Drug Code
  • 0409-2304 Corlopam 10 mg/ml Intravenous Injection, Solution by Hospira, Inc.
  • 0409-3373 Corlopam 10 mg/ml Intravenous Injection, Solution by Hospira, Inc.

Other drugs which contain Fenoldopam or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA